Search

everythinglearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

IGF-I promotes hair growth by keeping hair follicles in the growth phase longer.

Yifa Compound Prescription helps hair follicles grow better in lab conditions.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Focal atrichia helps diagnose female pattern hair loss.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

DFMO may help control hair growth and treat cancer.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Aloe Vera and injectable platelet-rich fibrin (i-PRF) together can speed up and improve hair growth when used in the right amounts.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.